Tetrahydropyran heterocyclic cyclopentyl heteroaryl modulators of chemokine receptor activity

Details for Australian Patent Application No. 2004263509 (hide)

Owner Merck & Co., Inc.

Inventors Goble, Stephen D.; Butora, Gabor; Yang, Lihu

Agent Spruson & Ferguson

Pub. Number AU-A-2004263509

PCT Pub. Number WO2005/014537

Priority 60/493,902 08.08.03 US

Filing date 6 August 2004

Wipo publication date 17 February 2005

International Classifications

C07D 407/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group

Event Publications

23 February 2006 PCT application entered the National Phase

  PCT publication WO2005/014537 Priority application(s): WO2005/014537

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

3 March 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004263512-Complexes of GPCR142 and relaxin3 or INSL5, and their production and use

2004263508-Aryl and heteroaryl compounds, compositions, and methods of use